Ata Mahmoodpoor1, Kamran Shadvar1, Sarvin Sanaie2, Mir Reza Hadipoor3, Mohammad Ata Pourmoghaddam4, Seied Hadi Saghaleini5. 1. Fellowship of critical care medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. 3. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Yeditepe Dental Student Association Research Committee Member, Faculty of Dentistry, Yeditepe University, Istanbul, Turkey. 5. Fellowship of critical care medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hsaghaleini@gmail.com.
Abstract
BACKGROUND:Critically ill patients frequently suffer from vitamin C deficiency. Previous studies showed that high doses of vitamin C administration had conflicting results on clinical outcomes in patients with severe sepsis, burns, and trauma. Because of the high incidence and morbidity/mortality with severe pneumonia, we aimed to investigate the effect of administration of high dose vitamin C in critically ill patients with severe pneumonia. METHODS:Eighty critically ill patients with pneumonia were enrolled in this randomized double-blinded clinical trial. Patients with a CURB-65 score > 3, one major criterion, or ≥ 3 minor criteria were considered as severe pneumonia. Patients were randomly assigned to intervention or placebo groups receiving standard treatment plus 60 mg/kg/day vitamin C as a continuous infusion or normal saline in the same volume correspondingly for 96 h. Serum levels of vitamin C were noted at baseline and 48 h after vitamin C administration. Duration of mechanical ventilation, ICU length of stay, PaO2/FiO2, and mortality rate were noted for all patients till the 28th day. Any complications related to the vitamin C administration were recorded. RESULTS:Duration of mechanical ventilation and vasopressor use were significantly lower in the intervention group (p: < 0.001 and 0.003, respectively). Baseline levels of vitamin C in both groups did not have a significant difference but its levels increased in the intervention group and decreased in the control group during the study period. Mortality rate insignificantly decreased in the intervention group (p = 0.17). Three patients showed hypotension and tachycardia during the administration of vitamin C which was self-limited with decreasing the dose of vitamin C. Our results showed that the intravenous administration of a relatively high dose of vitamin C to critically ill patients with severe pneumonia was safe and could decrease the inflammation, duration of mechanical ventilation, and vasopressor use without any significant effect on mortality. TRIAL REGISTRATION: IRCT registration number: IRCT20190312043030N1, Registration date: 2019-08-26, Seied Hadi Saghaleini.
RCT Entities:
BACKGROUND:Critically illpatients frequently suffer from vitamin C deficiency. Previous studies showed that high doses of vitamin C administration had conflicting results on clinical outcomes in patients with severe sepsis, burns, and trauma. Because of the high incidence and morbidity/mortality with severe pneumonia, we aimed to investigate the effect of administration of high dose vitamin C in critically illpatients with severe pneumonia. METHODS: Eighty critically illpatients with pneumonia were enrolled in this randomized double-blinded clinical trial. Patients with a CURB-65 score > 3, one major criterion, or ≥ 3 minor criteria were considered as severe pneumonia. Patients were randomly assigned to intervention or placebo groups receiving standard treatment plus 60 mg/kg/day vitamin C as a continuous infusion or normal saline in the same volume correspondingly for 96 h. Serum levels of vitamin C were noted at baseline and 48 h after vitamin C administration. Duration of mechanical ventilation, ICU length of stay, PaO2/FiO2, and mortality rate were noted for all patients till the 28th day. Any complications related to the vitamin C administration were recorded. RESULTS: Duration of mechanical ventilation and vasopressor use were significantly lower in the intervention group (p: < 0.001 and 0.003, respectively). Baseline levels of vitamin C in both groups did not have a significant difference but its levels increased in the intervention group and decreased in the control group during the study period. Mortality rate insignificantly decreased in the intervention group (p = 0.17). Three patients showed hypotension and tachycardia during the administration of vitamin C which was self-limited with decreasing the dose of vitamin C. Our results showed that the intravenous administration of a relatively high dose of vitamin C to critically illpatients with severe pneumonia was safe and could decrease the inflammation, duration of mechanical ventilation, and vasopressor use without any significant effect on mortality. TRIAL REGISTRATION: IRCT registration number: IRCT20190312043030N1, Registration date: 2019-08-26, Seied Hadi Saghaleini.
Entities:
Keywords:
Critically ill; Mortality; Pneumonia; Vitamin C
Authors: Alpha A Fowler; Jonathon D Truwit; R Duncan Hite; Peter E Morris; Christine DeWilde; Anna Priday; Bernard Fisher; Leroy R Thacker; Ramesh Natarajan; Donald F Brophy; Robin Sculthorpe; Rahul Nanchal; Aamer Syed; Jamie Sturgill; Greg S Martin; Jonathan Sevransky; Markos Kashiouris; Stella Hamman; Katherine F Egan; Andrei Hastings; Wendy Spencer; Shawnda Tench; Omar Mehkri; James Bindas; Abhijit Duggal; Jeanette Graf; Stephanie Zellner; Lynda Yanny; Catherine McPolin; Tonya Hollrith; David Kramer; Charles Ojielo; Tessa Damm; Evan Cassity; Aleksandra Wieliczko; Matthew Halquist Journal: JAMA Date: 2019-10-01 Impact factor: 56.272
Authors: Anitra C Carr; Patrice C Rosengrave; Simone Bayer; Steve Chambers; Jan Mehrtens; Geoff M Shaw Journal: Crit Care Date: 2017-12-11 Impact factor: 9.097
Authors: Harm-Jan de Grooth; Wai-Ping Manubulu-Choo; Anthe S Zandvliet; Angélique M E Spoelstra-de Man; Armand R Girbes; Eleonora L Swart; Heleen M Oudemans-van Straaten Journal: Chest Date: 2018-03-06 Impact factor: 9.410
Authors: Bernard J Fisher; Ignacio M Seropian; Donatas Kraskauskas; Jay N Thakkar; Norbert F Voelkel; Alpha A Fowler; Ramesh Natarajan Journal: Crit Care Med Date: 2011-06 Impact factor: 7.598
Authors: C L Long; K I Maull; R S Krishnan; H L Laws; J W Geiger; L Borghesi; W Franks; T C Lawson; H E Sauberlich Journal: J Surg Res Date: 2003-02 Impact factor: 2.192
Authors: Tomoko Fujii; Nora Luethi; Paul J Young; Daniel R Frei; Glenn M Eastwood; Craig J French; Adam M Deane; Yahya Shehabi; Ludhmila A Hajjar; Gisele Oliveira; Andrew A Udy; Neil Orford; Samantha J Edney; Anna L Hunt; Harriet L Judd; Laurent Bitker; Luca Cioccari; Thummaporn Naorungroj; Fumitaka Yanase; Samantha Bates; Forbes McGain; Elizabeth P Hudson; Wisam Al-Bassam; Dhiraj Bhatia Dwivedi; Chloe Peppin; Phoebe McCracken; Judit Orosz; Michael Bailey; Rinaldo Bellomo Journal: JAMA Date: 2020-02-04 Impact factor: 56.272
Authors: Patrice Rosengrave; Emma Spencer; Jonathan Williman; Jan Mehrtens; Stacey Morgan; Tara Doyle; Kymbalee Van Der Heyden; Anna Morris; Geoff Shaw; Anitra C Carr Journal: Crit Care Date: 2022-01-25 Impact factor: 9.097
Authors: Milan Kratochvíl; Jozef Klučka; Eva Klabusayová; Tereza Musilová; Václav Vafek; Tamara Skříšovská; Jana Djakow; Pavla Havránková; Denisa Osinová; Petr Štourač Journal: Children (Basel) Date: 2022-07-11